ライフサイエンスコーパス: vascular access

1 venting infections associated with long-term vascular access.

2 e remaining venous site to achieve permanent vascular access.

3 sted all upper extremity sites for permanent vascular access.

4 ated hospitalizations were not attributed to vascular access.

5 wo complications were noted, nine related to vascular access.

6 g/dL, and an arteriovenous fistula as their vascular access.

7 ar tachycardia after at least one shock, and vascular access.

8 starting hemodialysis predicted the type of vascular access.

9 were restenosis, thrombosis, and failure of vascular access.

10 the role of indoxyl sulfate in hemodialysis vascular access.

11 s occurred in 4 patients and were related to vascular access.

12 elays in providing consent (4.4%), difficult vascular access (8.4%), difficulty crossing the lesion (

13 fellowship programs in the following areas: vascular access (98%), lung and pleural (74%), cardiac (

14 Complications from vascular access account for 15% of hospital admissions a

15 use, and all hospitalizations not related to vascular access) also did not differ significantly betwe

16 prevention measures should include improved vascular access and CVC care.

17 s a composite end point including successful vascular access and deployment of the device and retriev

18 es and trials have advanced our knowledge of vascular access and different anticoagulation regimens.

19 rred for a third transplant due to decreased vascular access and progressive hypotension from uremic

20 can be selected depending on the quality of vascular access and the type of prosthesis used.

21 ity of RRT, delayed placement of a permanent vascular access, and delayed initiation of RRT.

22 rapeutic procedures involving needles and/or vascular access, and often they do so in darkened rooms.

23 Pharmacotherapy, vascular access, and the presentation and management of

24 Adults with nontraumatic OHCA, vascular access, and VF/VT anytime after >/=1 shock(s) w

25 methods, respectively); use of a fistula for vascular access; and measured single-pool Kt/V urea valu

26 The most common vascular access approach was transfemoral (4972 patients

27 Hemodialysis vascular accesses are prone to recurrent stenosis and th

28 grafts, an important option for hemodialysis vascular access, are prone to recurrent stenosis and thr

29 Type of permanent vascular access (arteriovenous fistula vs synthetic graf

30 to evaluate the associations between type of vascular access (arteriovenous fistula, arteriovenous gr

31 cessful creation and maintenance of reliable vascular access become a real challenge.

32 ents with advanced CKD who receive permanent vascular access before dialysis initiation are unclear.

33 galactosylceramide activated NKT1 cells with vascular access, but not LN or thymic NKT cells, resulti

34 Chronic vascular access can be maintained with minimal supervisi

35 or the administration of drugs and fluids if vascular access cannot be established.

36 .g., postoperative state, trauma, indwelling vascular access, certain medications).

37 the clinical and economic effects of initial vascular access choice.

38 Patients were classified into one of three vascular access choices: maintain CVC, attempt fistula,

39 the treatment area and patency of the entire vascular access circuit.

40 Doppler ultrasound and then be assigned to a vascular access class.

41 ar access type 2 yr after the translation of vascular access clinical practice guideline statements i

42 a permanent pacemaker, 1 patient (5%) had a vascular access complication requiring endovascular repa

43 mothorax, stroke, transient ischemic attack, vascular access complications (hemorrhage/hematoma, vasc

44 1, prior to radiofrequency application), and vascular access complications (n = 4).

45 Vascular access complications are a major cause of morbi

46 dize reporting of methods and definitions of vascular access complications in future clinical studies

47 lar access planning has been shown to reduce vascular access complications.

48 frequent hemodialysis increases the risk of vascular access complications.

49 ic flashlight than with conventional US, and vascular access could be gained in a cadaver; the sonic

50 to the nephrologist and timely placement of vascular access could result in reduced utilization and

51 ining, P < 0.0001) and degree of emphasis on vascular access creation during training (AOR = 2.4 for

52 s with advanced CKD who received predialysis vascular access creation initiated dialysis within 2 yea

53 and dialysis-free survival for 2 years after vascular access creation.

54 nvestigation of this question, a prospective vascular access database was queried retrospectively to

55 tion to angiographic data on vascularity and vascular access, demonstration of hepatocellular carcino

56 plantation success was defined as successful vascular access, deployment of a single device in the pr

57 Midlines are a type of vascular access device (VAD) used exclusively in one tre

58 erted central catheters (PICCs) are a common vascular access device used in clinical practice.

59 Vascular access devices (VADs) are frequently used in pa

60 Vascular access devices can be divided into external cat

61 bosis are serious complications of long-term vascular access devices in children undergoing chemother

62 g and are among the most heavily manipulated vascular access devices.

63 Mortality for delays due to difficult vascular access, difficulty crossing a lesion, and other

64 patients, a stented vessel was utilized for vascular access during subsequent cardiac surgery (n = 3

65 Vascular access dysfunction compromises the care of pati

66 Hemodialysis vascular access dysfunction contributes to increased mor

67 Vascular access dysfunction contributes to the mortality

68 Hemodialysis vascular access dysfunction is the single most important

69 ion failure is the primary cause of dialysis vascular access dysfunction.

70 led based on the commonality of the need for vascular access, extracorporeal blood volumes, and bedsi

71 ications are frequent causes of hemodialysis vascular access failure and contribute considerably to t

72 able strategy to treat AV graft hemodialysis vascular access failure.

73 monitoring program using ultrasound dilution vascular access flow technology to direct referral for a

74 scular access flow using ultrasound dilution vascular access flow technology, on FO/HTN and VAT in th

75 atocrit-guided ultrafiltration algorithm and vascular access flow using ultrasound dilution vascular

76 d hospitals of adult patients who required a vascular access for > or = 2 weeks.

77 , the mechanism is more complex than site of vascular access for BAS or exposure to central venous ca

78 uency, eight on dialysis accuracy, and 22 on vascular access for dialysis INTERPRETATION: Most patien

79 sease are often dehydrated and need adequate vascular access for fluid resuscitation, nutrition, and

80 r renal replacement therapy who had incident vascular access for HD created between January 1, 2006,

81 Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD).

82 teriovenous fistula is the preferred type of vascular access for hemodialysis because of lower thromb

83 enous fistula (AVF) is the preferred type of vascular access for hemodialysis but has high rates of d

84 nd an arteriovenous fistula as the preferred vascular access for hemodialysis, but quantitative assoc

85 nneled catheters are an alternative means of vascular access for patients in need of hemodialysis who

86 The Tesio catheter is a reasonable means of vascular access for patients who undergo dialysis but ar

87 al to the nephrologist, and use of temporary vascular access for the first dialysis.

88 versus 17%) or have a functioning permanent vascular access for the first hemodialysis (40% versus 4

89 Thrombosis of hemodialysis vascular access grafts represents a major medical and ec

90 Uniform vascular access guidelines for elderly patients may be i

91 is patients with central venous catheters as vascular access had their ScvO2 monitored during a 6-mon

92 Hemodialysis vascular access has emerged as a major cause of patient

93 ity of this preventive approach to long-term vascular access has not been established.

94 S-ICD may be ideal for patients with limited vascular access, high infection risk, or some congenital

95 s the initial access followed by a synthetic vascular access if the AVF did not mature compared to (2

96 n-related hospitalization was related to the vascular access in 21% of the cases, and non-access-rela

97 o have exhausted all options for a permanent vascular access in both upper extremities.

98 ntraosseous route provides fast and reliable vascular access in emergency medical situations.

99 teriovenous fistulae are the optimum form of vascular access in end-stage renal failure.

100 includes exceptionally high use of surgical vascular access in Japan and in some European countries,

101 m in September 2003, a new classification of vascular access in patients who were candidates for bowe

102 Loss of vascular access in patients with intestinal failure is c

103 ta characterizes the profile of hemodialysis vascular access in the United States and identifies dete

104 analyzed; outcomes of interest were type of vascular access in use (fistula vs. graft) in hemodialys

105 en though catheters represented only 7.6% of vascular accesses in the study.

106 are likely to be multifactorial and include vascular access infection, less-than-sterile dialysate,

107 tion of practice guidelines for hemodialysis vascular access into national CPMs, there is substantial

108 Placement of right atrial catheters for vascular access is a common operative procedure.

109 Vascular access is a principal cause of morbidity and co

110 The ability to gain vascular access is often impaired because of large body

111 f ECLS included veno-venous or veno-arterial vascular access, lung "rest" at low FiO2 and inspiratory

112 l wall of the internal jugular in a lifelike vascular access mannequin in the majority of cases.

113 d that the maintenance and placement of ESRD vascular access may account for up to 25% of the ESRD bu

114 Reoperations are frequent; peripheral vascular access may be compromised and sternal reentry i

115 egarding risks/benefits associated with each vascular access (mean knowledge score 3/5 (95% confidenc

116 The vascular access monitoring program using ultrasound dilu

117 Frequent hemodialysis requires using the vascular access more often than with conventional hemodi

118 Component blocks include large bore vascular access, navigation within the left atrium, occl

119 logist, according to National Association of Vascular Access Networks guidelines, and the initial PIC

120 Vascular access nurses and their perceived role as part

121 ge (93%) of valued consultants reported that vascular access nurses placed the majority of PICCs at t

122 This sample was further restricted to vascular access nurses who worked in a U.S. hospital (n=

123 We examined vascular access nurses' perceived role related to use of

124 The presence and proliferation of vascular access nursing in hospital settings has been id

125 Clotting of the vascular access occurred in two patients when the dose o

126 s an individualized approach to hemodialysis vascular access, on the basis of each patient's unique b

127 Vascular access options in coronary angiography can be c

128 g static (vs dynamic) ultrasound guidance of vascular access or the use of needle guide devices.

129 The primary vascular access outcome was time to first access event (

130 outlines the financial barriers to improved vascular access outcomes and our proposals for a future

131 s fistula (AVF) maturation failure, and poor vascular access outcomes in this population.

132 sults underscore the importance of including vascular access patency in future studies of BP manageme

133 allowed us to identify the first predialysis vascular access placed rather than the first access used

134 all-cause mortality outcomes based on first vascular access placed, considering the fistula group as

135 are claims to identify the first predialysis vascular access placed.

136 other countries) and noted less emphasis on vascular access placement compared with surgeons elsewhe

137 of the 70 patients who underwent mapping had vascular access placement.

138 In addition, CT-based vascular access planning has been shown to reduce vascul

139 Subcutaneous vascular access port patency was maintained up to 136 da

140 Subcutaneous vascular access ports were surgically placed in each mon

141 Initial attempts were complicated by vascular access problems and lack of appropriate tools.

142 ed survey was administered to members of two vascular access professional organizations.

143 A vascular access PtDA for eligible patients undergoing co

144 One hundred fifty patients were randomized (vascular access PtDA=76 versus usual care=74).

145 better informed value congruence with their vascular access received (47.3% versus 25.7%, P<0.01).

146 < .05) associated with having a catheter for vascular access; receiving treatment on a Monday, Wednes

147 or patient demographics, months on dialysis, vascular access, recently treated infections, signs and

148 These include noncompliance, vascular access recirculation, and dialyzer dysfunction.

149 Hemodialysis vascular access recommendations promote arteriovenous (A

150 atening TPN complications, including lack of vascular access, recurrent line infections, and intermit

151 ar, infection-related, fracture-related, and vascular access-related hospitalization.

152 M was associated with higher nonvascular and vascular access-related hospitalizations and mortality c

153 e in serum albumin levels or ACM, or all non-vascular access-related hospitalizations.

154 even (53.8%) of the 13 patients with primary vascular access-related infections had concurrent metast

155 asked with recommending measures to decrease vascular access-related infections.

156 plasma total homocysteine (tHcy) levels and vascular access-related morbidity was examined in a coho

157 These results suggest that vascular access-related outcomes may be optimized by con

158 he maintenance and longevity of hemodialysis vascular access remains one of the most problematic topi

159 designed to identify potential predictors of vascular access site (VAS) complications in the large-sc

160 The vascular access site complication rate was 1.5%.

161 ated with a 0.40% absolute risk reduction in vascular access site complications (95% confidence inter

162 e cumulative incidence of major bleeding and vascular access site complications at 30 days.

163 effectiveness of ACDs for the prevention of vascular access site complications in patients undergoin

164 The rate of vascular access site complications was 9.3% in the enoxa

165 The main outcome measure was vascular access site complications, and nonaccess site b

166 perforation, device dislocation, and femoral vascular access site complications.

167 Adverse bleeding events, largely related to vascular access site hemorrhage, were slightly increased

168 nced a major hemorrhage, which occurred at a vascular access site in six patients.

169 The association between femoral arterial vascular access site management (manual pressure [includ

170 The vascular access site was predominantly transradial in th

171 Major bleeding at the vascular access site, hemolysis, and pericardial tampona

172 k of bleeding, particularly from the femoral vascular access site, may be reduced through the use of

173 njury (AKI) after PCI might be influenced by vascular access site.

174 eding complications seem to relate mainly to vascular/access site complications (related to the use o

175 oninferior to manual compression in terms of vascular access-site complications and reduced time to h

176 Vascular access-site complications occurred in 4 patient

177 oninferior to manual compression in terms of vascular access-site complications.

178 n models: 1) clinical factors; 2) clinical + vascular access strategies (femoral vs. radial, use of c

179 model was implemented to compare 2 different vascular access strategies among incident dialysis patie

180 as associated with a 10% increase in odds of vascular access surgery (95% confidence interval, 8% to

181 Upper extremity vascular access surgery using polytetrafluorethylene (PT

182 t mature compared to (2) placing a synthetic vascular access (SVA1st) as the initial access device.

183 scribed time or blood flow rates followed by vascular access testing.

184 ertension (9%), anemia (9%), infection (7%), vascular access thrombosis (2%), stroke (2%), and bowel

185 ere fluid overload/hypertension (FO/HTN) and vascular access thrombosis (VAT).

186 There were 2005 total episodes of vascular access thrombosis during a median 3.1 years of

187 able risk factors to reduce the incidence of vascular access thrombosis in hemodialysis could reduce

188 Our primary outcome measure was episodes of vascular access thrombosis occurring within a given 6-mo

189 cardiovascular events, hospitalizations, and vascular access thrombosis, respectively.

190 ystolic BP associate with increased rates of vascular access thrombosis.

191 olic BP were associated with higher rates of vascular access thrombosis.

192 Vascular access thrombotic episodes were recorded over a

193 Overall, participants achieved faster vascular access times with sonic flashlight guidance (P

194 After propensity score matching, the median vascular access-to-balloon time was 4 to 6 minutes short

195 ith a statistically significant reduction in vascular access-to-balloon time, although the 4- to 6-mi

196 ent with conventional US performed simulated vascular access trials on three tasks with the sonic fla

197 with no US experience performed 60 simulated vascular access trials with sonic flashlight or conventi

198 <60 mg(2)/dl(2)), dose (Kt/V > or =1.2), and vascular access type (fistula); hospitalization rates; a

199 United States and identifies determinants of vascular access type 2 yr after the translation of vascu

200 lysis, but quantitative associations between vascular access type and various clinical outcomes remai

201 data describing study design, participants, vascular access type, clinical outcomes, and risk for bi

202 Gender, body mass index, weight, vascular access type, length, site, and mode of continuo

203 A recent national survey of vascular access types among incident American hemodialys

204 nd cardiovascular events compared with other vascular access types, and patients with usable fistulas

205 Incident vascular access use rates and mortality.

206 th an arteriovenous fistula, but the role of vascular access (VA) type in the morbidity and mortality

207 Intraosseous vascular access was easily established in all animals, a

208 In study 3, sonic flashlight-guided vascular access was gained in the cadaver.

209 Although ultrasound training in vascular access was nearly universal, training in other

210 n section to avoid steroid-induced abortion; vascular access was obtained, and the fetuses were venti

211 Rats were anesthetized with halothane and vascular access was obtained.

212 Vascular access was transfemoral (n = 35), subclavian (n

213 Vascular access was via the left axillary vein.

214 15%, respectively, and claims for permanent vascular access were found for only 30% of hemodialysis

215 al to the nephrologist and lack of permanent vascular access were independently associated with incre

216 No complications related to the device or vascular access were observed during follow-up.

217 Learning and performance of vascular access were significantly faster with the sonic

218 access time over trials) did not differ for vascular access with sonic flashlight and conventional U